PROCEPT BioRobotics
PRCT
Performance
About PROCEPT BioRobotics
PROCEPT BioRobotics is a medical device company focused on advancing urology through robotic-assisted treatments, notably Aquablation therapy for benign prostatic hyperplasia. The company develops and promotes ultrasound-guided, waterjet-based robotic systems such as AquaBeam and HYDROS to assist surgeons in achieving precise prostate tissue removal. With patient care and surgeon empowerment as core goals, PROCEPT BioRobotics emphasizes evidence from clinical data and a global reach across healthcare providers and markets.
Recent News
Edwards Lifesciences Reports Double-Digit Pay Increases for Executives and Median Employee
Siemens Healthineers, AiM Team up; Procept Completes Study Enrollment
Procept Secures FDA IDE for Aquablation and Completes WATER IV Study Enrolment
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
Recent Deals
No recent deals for this company.